Mitochondrial Dysfunction, Oxidative Stress and Neuroinflammation in Neurodegeneration with Brain Iron Accumulation (NBIA)
- PMID: 33092153
- PMCID: PMC7589120
- DOI: 10.3390/antiox9101020
Mitochondrial Dysfunction, Oxidative Stress and Neuroinflammation in Neurodegeneration with Brain Iron Accumulation (NBIA)
Abstract
The syndromes of neurodegeneration with brain iron accumulation (NBIA) encompass a group of invalidating and progressive rare diseases that share the abnormal accumulation of iron in the basal ganglia. The onset of NBIA disorders ranges from infancy to adulthood. Main clinical signs are related to extrapyramidal features (dystonia, parkinsonism and choreoathetosis), and neuropsychiatric abnormalities. Ten NBIA forms are widely accepted to be caused by mutations in the genes PANK2, PLA2G6, WDR45, C19ORF12, FA2H, ATP13A2, COASY, FTL1, CP, and DCAF17. Nonetheless, many patients remain without a conclusive genetic diagnosis, which shows that there must be additional as yet undiscovered NBIA genes. In line with this, isolated cases of known monogenic disorders, and also, new genetic diseases, which present with abnormal brain iron phenotypes compatible with NBIA, have been described. Several pathways are involved in NBIA syndromes: iron and lipid metabolism, mitochondrial dynamics, and autophagy. However, many neurodegenerative conditions share features such as mitochondrial dysfunction and oxidative stress, given the bioenergetics requirements of neurons. This review aims to describe the existing link between the classical ten NBIA forms by examining their connection with mitochondrial impairment as well as oxidative stress and neuroinflammation.
Keywords: autophagy; brain iron accumulation; iron metabolism; lipid metabolism; membrane remodelling; mitochondrial dysfunction; neurodegenerative disorder; neuroinflammation; oxidative stress; rare disease.
Conflict of interest statement
The authors declare no conflict of interest.
Figures

Similar articles
-
On the complexity of clinical and molecular bases of neurodegeneration with brain iron accumulation.Clin Genet. 2018 Apr;93(4):731-740. doi: 10.1111/cge.13057. Epub 2017 Sep 25. Clin Genet. 2018. PMID: 28542792 Review.
-
Review: Insights into molecular mechanisms of disease in neurodegeneration with brain iron accumulation: unifying theories.Neuropathol Appl Neurobiol. 2016 Apr;42(3):220-41. doi: 10.1111/nan.12242. Epub 2015 Jun 2. Neuropathol Appl Neurobiol. 2016. PMID: 25870938 Free PMC article. Review.
-
Neurodegeneration with brain iron accumulation: Insights into the mitochondria dysregulation.Biomed Pharmacother. 2019 Oct;118:109068. doi: 10.1016/j.biopha.2019.109068. Epub 2019 Aug 9. Biomed Pharmacother. 2019. PMID: 31404774 Review.
-
Novel mutations in PANK2 and PLA2G6 genes in patients with neurodegenerative disorders: two case reports.BMC Med Genet. 2017 Aug 18;18(1):87. doi: 10.1186/s12881-017-0439-y. BMC Med Genet. 2017. PMID: 28821231 Free PMC article.
-
Neurodegeneration with brain iron accumulation.Handb Clin Neurol. 2018;147:293-305. doi: 10.1016/B978-0-444-63233-3.00019-1. Handb Clin Neurol. 2018. PMID: 29325618 Free PMC article. Review.
Cited by
-
Case Report: Identification of a De novo C19orf12 Variant in a Patient With Mitochondrial Membrane Protein-Associated Neurodegeneration.Front Genet. 2022 Mar 30;13:852374. doi: 10.3389/fgene.2022.852374. eCollection 2022. Front Genet. 2022. PMID: 35432442 Free PMC article.
-
Alpha-lipoic acid supplementation corrects pathological alterations in cellular models of pantothenate kinase-associated neurodegeneration with residual PANK2 expression levels.Orphanet J Rare Dis. 2023 Apr 12;18(1):80. doi: 10.1186/s13023-023-02687-5. Orphanet J Rare Dis. 2023. PMID: 37046296 Free PMC article.
-
Comprehensive Bioinformatics Analysis Reveals the Potential Role of the hsa_circ_0001081/miR-26b-5p Axis in Regulating COL15A1 and TRIB3 within Hypoxia-Induced miRNA/mRNA Networks in Glioblastoma Cells.Biomedicines. 2024 Oct 1;12(10):2236. doi: 10.3390/biomedicines12102236. Biomedicines. 2024. PMID: 39457549 Free PMC article.
-
Cognitive and Physical Intervention in Metals' Dysfunction and Neurodegeneration.Brain Sci. 2022 Mar 3;12(3):345. doi: 10.3390/brainsci12030345. Brain Sci. 2022. PMID: 35326301 Free PMC article. Review.
-
Iron Deposition in Parkinson's Disease: A Mini-Review.Cell Mol Neurobiol. 2024 Feb 23;44(1):26. doi: 10.1007/s10571-024-01459-4. Cell Mol Neurobiol. 2024. PMID: 38393383 Free PMC article. Review.
References
-
- Espinós C., Galindo M.I., Garcia-Gimeno M.A., Ibañez-Cabellos J.S., Martinez-Rubio D., Millan J.M., Rodrigo R., Sanz P., Seco-Cervera M., Sevilla T., et al. Oxidative Stress, a Crossroad between Rare Diseases and Neurodegeneration. Antioxidants. 2020;9:313. doi: 10.3390/antiox9040313. - DOI - PMC - PubMed
-
- Correa-Vela M., Lupo V., Montpeyo M., Sancho P., Marce-Grau A., Hernandez-Vara J., Darling A., Jenkins A., Fernandez-Rodriguez S., Tello C., et al. Impaired proteasome activity and neurodegeneration with brain iron accumulation in FBXO7 defect. Ann. Clin. Transl. Neurol. 2020;7:1436–1442. doi: 10.1002/acn3.51095. - DOI - PMC - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous